Matthews International Capital Management LLC Staar Surgical CO Transaction History

Matthews International Capital Management LLC

$589 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$50.45 - $72.82 $954,867 - $1.38 Million	-18,927 Reduced 15.66%	101,938 $5.36 Million
Q1 2023 May 10, 2023	BUY	$51.25 - $79.34 $6.19 Million - $9.59 Million	120,865 New	120,865 $7.73 Million
Q4 2020 Feb 09, 2021	SELL	$55.93 - $82.78 $307,615 - $455,290	-5,500 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$45.65 - $61.81 $497,585 - $673,729	-10,900 Reduced 66.46%	5,500 $311,000
Q2 2020 Jul 29, 2020	SELL	$29.15 - $61.54 $137,005 - $289,238	-4,700 Reduced 22.27%	16,400 $1.01 Million
Q1 2020 May 11, 2020	BUY	$25.01 - $42.4 $527,711 - $894,640	21,100 New	21,100 $681,000

Others Institutions Holding STAA

# of Institutions

251

Shares Held

47.3M

Call Options Held

427K

Put Options Held

206K

View Full List

About STAAR SURGICAL CO

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

More about STAA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Account